Cambridgeshire and Peterborough
Formulary Chapter 2: Cardiovascular system -
Local Process for warfarin to DOAC switch_April 2020
DOAC Counselling Checklist
National Guidance: Warfarin to DOAC switching _ April 2020
Warfarin to DOAC switching _ Local Guidance _ April 2020
NICE CG187: Acute heart failure: diagnosis and management
UKMI: MI - secondary prevention - Summary of NICE guidance (CG172)
Angiotensin-II receptor antagonists
Sacubitril / valsartan
Specialist initiation by Heart Failure Specialist with access to MDT as per
NICE TA388: Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction
Prescribing Support: Sacubitril/valsartan (Entresto)
: Formulary (
at all other Trusts.
Prescribe as capsules in
at all other Trusts
ACEi & A2A MeReC review (2010)
NICE Key therapeutic topic [KTT2]: Renin-angiotensin system drugs - dual therapy
Non Formulary Items
(Losartan & hydrochlorothiazide)
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
High Cost Medicine
Cancer Drugs Fund
Traffic Light Status Information
Available Over the Counter. Consider Self Care
Formulary - Can be prescribed in both secondary and primary care.
Formulary - Specialist Advice, secondary care advice provided for primary care initiation.
Formulary - Specialist initiation without shared care guidance.
Formulary - Specialist initiation with shared care guidance.
Restricted - Hospital only, not to be prescribed in primary care.
Not recommended for prescribing. Switch to alternative cost-effective option.
Not recommended for prescribing in primary or secondary care.
Not recommended as no formal application made for addition to the formulary. Contact relevant pharmacy team for further information.
Non-Formulary (category under review).